Ibrutinib
Ibrutinib | |
---|---|
Term | Ibrutinib |
Short definition | ibrutinib (i-BROO-tih-nib) A drug used alone or with other drugs to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom's macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma or marginal zone lymphoma. It is also used to treat adults and children over 1 year old with chronic graft-versus-host disease. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
ibrutinib - (pronounced) (i-BROO-tih-nib) A drug used alone or with other drugs to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom's macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma or marginal zone lymphoma. It is also used to treat adults and children over 1 year old with chronic graft-versus-host disease. It is also being studied in the treatment of other types of cancer. Ibrutinib blocks a protein called BTK, which can help prevent cancer cells from growing. It can also decrease the body's immune response. Ibrutinib is a type of tyrosine kinase inhibitor. Also called Imbruvica
External links
- Medical encyclopedia article on Ibrutinib
- Wikipedia's article - Ibrutinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski